Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Q3/11: Tali NDA on Track, Cerezyme Shortage Continues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. SPCX
7. AVGO
8. RMAX
9. HD
10. BJ

Go back to Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Q3/11: Tali NDA on Track, Cerezyme Shortage Continues
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.38 --0 (-0%)
Previous Close $2.38    52 Week High $1.11 
Open $2.39    52 Week Low $0.41 
Day High $2.44    P/E N/A 
Day Low $2.35    EPS $-0.29 
Volume 648,550